DBCG 07-READ: A randomized phase III trial comparing six cycles of docetaxel and cyclophosphamide (DC) to three cycles of epirubicin and cyclophosphamide followed by three cycles of docetaxel (EC-D) in patients with early breast cancer

Bent Ejlertsen, Malgorzata K. Tuxen, Erik Hugger Jakobsen, Maj-Britt Jensen, Ann Knoop, Inger Højris, Marianne Ewertz, Eva Balslev, Peter Michael Vestlev, Julia Kenholm, Dorte L. Nielsen, Troels Bechmann, Michael Andersson, Søren Cold, Hanne M Nielsen, Else Maae, Dorte Carlsen, Henning T Mouridsen

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Original languageEnglish
Publication date2016
Publication statusPublished - 2016

Cite this